Want to join the conversation?
For FY16, $EMR's underlying sales is expected to be down 5-6% excluding negative currency translation and an impact from completed divestitures of approx. 2% each. Reported sales is expected to be down 9-10%. Reported EPS is now expected to be between $2.37-2.55, while adjusted EPS is revised to $2.37-2.55 from $3.05-3.25.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.